These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2462830)
81. Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase. Naparstek Y; Cohen IR; Fuks Z; Vlodavsky I Nature; 1984 Jul 19-25; 310(5974):241-4. PubMed ID: 6205275 [TBL] [Abstract][Full Text] [Related]
82. Mechanisms of resistance to autoimmune disease induced by T-cell vaccination. Lohse AW; Cohen IR Autoimmunity; 1991; 9(2):119-21. PubMed ID: 1932518 [No Abstract] [Full Text] [Related]
83. The study and manipulation of experimental autoimmune disease using T lymphocyte lines. Cohen IR J Invest Dermatol; 1985 Jul; 85(1 Suppl):34s-38s. PubMed ID: 3874248 [TBL] [Abstract][Full Text] [Related]
84. Immunoregulation: studies of physiological and therapeutic autoreactivity by T cell vaccination. Lohse AW; Cohen IR Springer Semin Immunopathol; 1992; 14(2):179-86. PubMed ID: 1475743 [No Abstract] [Full Text] [Related]
85. Inhibition of passive allergic encephalomyelitis by sulfated polysaccharides. Willenborg DO; Parish CR Ann N Y Acad Sci; 1988; 540():543-5. PubMed ID: 2974689 [No Abstract] [Full Text] [Related]
86. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Lider O; Reshef T; Beraud E; Ben-Nun A; Cohen IR Science; 1988 Jan; 239(4836):181-3. PubMed ID: 2447648 [TBL] [Abstract][Full Text] [Related]
87. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Ben-Nun A; Wekerle H; Cohen IR Nature; 1981 Jul; 292(5818):60-1. PubMed ID: 6974307 [No Abstract] [Full Text] [Related]
88. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Lohse AW; Mor F; Karin N; Cohen IR Science; 1989 May; 244(4906):820-2. PubMed ID: 2471264 [TBL] [Abstract][Full Text] [Related]
89. Physiological basis of T-cell vaccination against autoimmune disease. Cohen IR Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():879-84. PubMed ID: 2484252 [No Abstract] [Full Text] [Related]
90. Attenuated T-lymphocyte lines as vaccinating agents against experimental autoimmune encephalomyelitis. Offner H; Jones R; Vandenbark AA Ann N Y Acad Sci; 1988; 540():540-2. PubMed ID: 2462830 [No Abstract] [Full Text] [Related]
91. Myelin basic protein: structure, function and antigenic determinants. Hashim GA Immunol Rev; 1978; 39():60-107. PubMed ID: 75170 [No Abstract] [Full Text] [Related]
92. Vaccination against experimental autoimmune disease using autoimmune T-lymphocytes. Cohen IR Isr J Med Sci; 1988 Dec; 24(12):734-6. PubMed ID: 2465284 [No Abstract] [Full Text] [Related]
93. Autoimmune demyelination in the central nervous system. Tabira T Ann N Y Acad Sci; 1988; 540():187-201. PubMed ID: 2462801 [TBL] [Abstract][Full Text] [Related]
94. The mechanisms and applications of T cell vaccination for autoimmune diseases: a comprehensive review. Huang X; Wu H; Lu Q Clin Rev Allergy Immunol; 2014 Oct; 47(2):219-33. PubMed ID: 25096807 [TBL] [Abstract][Full Text] [Related]